csirt@kutim:~/threat-intel/cve/CVE-2026-23350

Katalog CVE

CVSS 7.8 · High EPSS 0,13%

Kerentanan Missing Release of Memory after Effective Lifetime pada linux kernel. Skor CVSS 3.1 7.8 (High) menurut CNA.

Deskripsi (NVD)

In the Linux kernel, the following vulnerability has been resolved: drm/xe/queue: Call fini on exec queue creation fail Every call to queue init should have a corresponding fini call. Skipping this would mean skipping removal of the queue from GuC list (which is part of guc_id allocation). A damaged queue stored in exec_queue_lookup list would lead to invalid memory reference, sooner or later. Call fini to free guc_id. This must be done before any internal LRCs are freed. Since the finalization with this extra call became very similar to __xe_exec_queue_fini(), reuse that. To make this reuse possible, alter xe_lrc_put() so it can survive NULL parameters, like other similar functions. v2: Reuse _xe_exec_queue_fini(). Make xe_lrc_put() aware of NULLs. (cherry picked from commit 393e5fea6f7d7054abc2c3d97a4cfe8306cd6079)

Rincian

Terbit di NVD
25 Maret 2026
Terakhir diubah
17 Juni 2026
Status NVD
Analyzed
CVSS 3.1
7.8 (High), sumber CNA
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H · uraikan di kalkulator
Jenis kelemahan (CWE)
CWE-401: Missing Release of Memory after Effective Lifetime
EPSS (30 hari)
0,13% peluang dieksploitasi; lebih tinggi dari 2,2% CVE lain

Produk dan versi terdampak

VendorProdukVersi terdampak
linux linux kernel Versi 6.19.1 hingga sebelum 6.19.7
linux linux kernel Versi 6.19
linux linux kernel Versi 7.0 rc1
linux linux kernel Versi 7.0 rc2
linux linux kernel Versi 7.0 rc3
linux linux kernel Versi 7.0 rc4
linux linux kernel Versi 7.0 rc5
linux linux kernel Versi 7.0 rc6
linux linux kernel Versi 7.0 rc7

> Data dari konfigurasi CPE di NVD.

Referensi dan perbaikan

Sumber: NVD · CVE.org · EPSS. Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:11 WITA. Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat kanal pelaporan.